LISAvienna Newsletter November 2025

Have a look at our curated list of news items, events and funding opportunities.

A few highlights:

From Stockholm to Vienna: #BIOEurope2025 and where to meet LISAvienna in the next months
Boehringer Ingelheim Innovation Prize 2024 goes to Ablevia biotech
What to know about Cutanos and KHAN Technology Transfer Fund I
Videos introducing a few participants in #REG24 (ingenetix | Roche und AUSTROMED | Brainhero) and one of our neighbors at the Vienna BioCenter (aitiologic)
News from Novasign | AIT Austrian Institute of Technology | MedUni Vienna | Takeda | UpNano | BOKU University | Vetmeduni Vienna | SOMAREALITY | ImageBiopsy Lab | Schrack Seconet | Jungbunzlauer | SCARLETRED | Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie | Evercyte | DirectSens | VALANX Biotech | Revo Foods | QUANTRO Therapeutics and many others
Funding opportunities at aws, FFG, Vienna Business Agency, EIT Health, CDG, LBG etc.

Would your life sciences company or research institution based in Vienna also like to be mentioned in our newsletter? We look forward to hearing from you.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna Newsletter November 2025

A few highlights:

Zweiter Workshop des One Health Network Austria an der Vetmeduni

Uni Vienna: Conservation paradox: Invasive species are often threatened in their native range

acib: 3.6 Millionen Euro für Innovation in der biopharmazeutischen Produktion